---
figid: PMC5883534__12918_2018_554_Fig4_HTML
figlink: /pmc/articles/PMC5883534/figure/Fig4/
number: F4
caption: Pathway analysis of BRAF kinase                                 inhibitor
  resistance shows alternative activation of MAPK targets                                 and
  pigmentation. a Schematic representation of                                 regulatory
  network involving drug inhibition and non-genomic                                 selection
  for differential expression of driver genes that can                                 circumvent
  suppressed signaling. b Deregulation of MAPK                                 signaling
  with RNA-Seq data is mapped in red and blue for                                 differential
  upregulation and downregulation, respectively.                                     c
  Modulation of TGFB signaling leads to                                 downregulation
  of dual specific phosphatases, which are required to                                 switch
  MAPK signaling off. d Interconnectedness between                                 G-protein
  signaling and melanogenesis. Alternative activation of                                 melanoma
  pathways leads to increased eumelanin synthesis and                                 mitogenic
  survival. Photograph of cell pellets of melanoma cell                                 models
  and detected melanin. Left shows SK-MEL-28 melanoma cell                                 line,
  middle and right shows two different SK-MEL-28-BRAFi-resistant                                 melanoma
  cell lines with elevated melanin                             production
pmcid: PMC5883534
papertitle: Systems biology analysis of mitogen activated protein kinase                     inhibitor
  resistance in malignant melanoma.
reftext: Helma Zecena, et al. BMC Syst Biol. 2018;12:33.
pmc_ranked_result_index: '2283'
pathway_score: 0.864619
filename: 12918_2018_554_Fig4_HTML.jpg
figtitle: BRAF kinase inhibitor resistance and alternative activation of MAPK targets
  and pigmentation
year: '2018'
organisms:
- Trichomonas brixi
- Homo sapiens
- Bos taurus
ndex: 72792c06-deb2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5883534__12918_2018_554_Fig4_HTML.html
  '@type': Dataset
  description: Pathway analysis of BRAF kinase                                 inhibitor
    resistance shows alternative activation of MAPK targets                                 and
    pigmentation. a Schematic representation of                                 regulatory
    network involving drug inhibition and non-genomic                                 selection
    for differential expression of driver genes that can                                 circumvent
    suppressed signaling. b Deregulation of MAPK                                 signaling
    with RNA-Seq data is mapped in red and blue for                                 differential
    upregulation and downregulation, respectively.                                     c
    Modulation of TGFB signaling leads to                                 downregulation
    of dual specific phosphatases, which are required to                                 switch
    MAPK signaling off. d Interconnectedness between                                 G-protein
    signaling and melanogenesis. Alternative activation of                                 melanoma
    pathways leads to increased eumelanin synthesis and                                 mitogenic
    survival. Photograph of cell pellets of melanoma cell                                 models
    and detected melanin. Left shows SK-MEL-28 melanoma cell                                 line,
    middle and right shows two different SK-MEL-28-BRAFi-resistant                                 melanoma
    cell lines with elevated melanin                             production
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CREB3
  - EFNA2
  - DUSP2
  - EP300
  - EPAS1
  - DCT
  - FGFR1
  - GNAI2
  - BRAF
  - EPHA2
  - MAP3K19
  - MAPK14
  - DUSP1
  - FGF1
  - MAP3K8
  - ARAF
  - MAP3K15
  - EDNRB
  - MAP2K2
  - MAP2K1
  - MAP3K21
  - MAP3K2
  - ADCY1
  - MAP3K20
  - TAOK1
  - HGF
  - MAP3K7
  - MAP3K12
  - RAF1
  - MAP3K14
  - MAPK12
  - MAPK13
  - MAP3K6
  - MAPK3
  - MAPK1
  - MAPK8
  - MAPK9
  - MAPK10
  - MAP3K3
  - MAP2K7
  - MAP2K6
  - MAP3K13
  - TAOK2
  - MAPK11
  - MITF
  - OCA2
  - PDGFC
  - PDGFRA
  - PLCB4
  - PRKACA
  - MAP3K1
  - PRKCA
  - KRAS
  - HRAS
  - MAP2K4
  - MAP2K5
  - MAP2K3
  - MAP3K11
  - TAOK3
  - TGFBR2
  - TGFBR3
  - TYR
  - YAP1
  - MAP3K4
  - TGFBR1
  - MAP3K9
  - MET
  - TF
  - MAP3K5
  - NRAS
  - SMAD2
  - MAP3K10
  - TGFB3
  - SMAD9
  - SMAD3
  - PLX4032
  - O-PLX4032
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Melanoma
  - Noonan syndrome
genes:
- word: CREB3
  symbol: CREB3
  source: hgnc_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: EFNA2
  symbol: EFNA2
  source: hgnc_symbol
  hgnc_symbol: EFNA2
  entrez: '1943'
- word: DUSP1/2
  symbol: DUSP2
  source: hgnc_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: EP300
  symbol: EP300
  source: hgnc_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: EPAS1
  symbol: EPAS1
  source: hgnc_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: DCT
  symbol: DCT
  source: hgnc_symbol
  hgnc_symbol: DCT
  entrez: '1638'
- word: FGFR1
  symbol: FGFR1
  source: hgnc_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: GNAI2
  symbol: GNAI2
  source: hgnc_symbol
  hgnc_symbol: GNAI2
  entrez: '2771'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: EPHA2
  symbol: EPHA2
  source: hgnc_symbol
  hgnc_symbol: EPHA2
  entrez: '1969'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K19
  entrez: '80122'
- word: ERK/P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: DUSP1/2
  symbol: DUSP1
  source: hgnc_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: FGF1
  symbol: FGF1
  source: hgnc_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K8
  entrez: '1326'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K15
  entrez: '389840'
- word: EDNRB
  symbol: EDNRB
  source: hgnc_symbol
  hgnc_symbol: EDNRB
  entrez: '1910'
- word: MAP2K
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAP2K
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K21
  entrez: '84451'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K2
  entrez: '10746'
- word: ADCY1
  symbol: ADCY1
  source: hgnc_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K20
  entrez: '51776'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: TAOK1
  entrez: '57551'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K7
  entrez: '6885'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K12
  entrez: '7786'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K14
  entrez: '9020'
- word: ERK/P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: ERK/P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K6
  entrez: '9064'
- word: ERK/P38O
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK/P38O
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K3
  entrez: '4215'
- word: MAP2K
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K7
  entrez: '5609'
- word: MAP2K
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K6
  entrez: '5608'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K13
  entrez: '9175'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: TAOK2
  entrez: '9344'
- word: ERK/P38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MITF
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: OCA2
  symbol: OCA2
  source: hgnc_symbol
  hgnc_symbol: OCA2
  entrez: '4948'
- word: PDGFC
  symbol: PDGFC
  source: hgnc_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PDGFRA
  symbol: PDGFRA
  source: hgnc_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: PLCB4
  symbol: PLCB4
  source: hgnc_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PRKACA
  symbol: PRKACA
  source: hgnc_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K1
  entrez: '4214'
- word: PRKCA
  symbol: PRKCA
  source: hgnc_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAP2K
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K4
  entrez: '6416'
- word: MAP2K
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K5
  entrez: '5607'
- word: MAP2K
  symbol: MAP2K
  source: bioentities_symbol
  hgnc_symbol: MAP2K3
  entrez: '5606'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K11
  entrez: '4296'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: TAOK3
  entrez: '51347'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR2
  entrez: '7048'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR3
  entrez: '7049'
- word: TYR
  symbol: TYR
  source: hgnc_symbol
  hgnc_symbol: TYR
  entrez: '7299'
- word: YAP1
  symbol: YAP1
  source: hgnc_symbol
  hgnc_symbol: YAP1
  entrez: '10413'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K4
  entrez: '4216'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: TGFBR
  symbol: TGFBR
  source: bioentities_symbol
  hgnc_symbol: TGFBR1
  entrez: '7046'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K9
  entrez: '4293'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K5
  entrez: '4217'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: SMAD2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: MAP3K
  symbol: MAP3K
  source: bioentities_symbol
  hgnc_symbol: MAP3K10
  entrez: '4294'
- word: TGFB3
  symbol: TGFB3
  source: hgnc_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: SMAD9
  symbol: SMAD9
  source: hgnc_symbol
  hgnc_symbol: SMAD9
  entrez: '4093'
- word: SMAD2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
chemicals:
- word: PLX4032
  source: MESH
  identifier: C551177
- word: O-PLX4032
  source: MESH
  identifier: C551177
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC5883534__F4
redirect_from: /figures/PMC5883534__F4
figtype: Figure
---
